InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Explore the full record of transactions filed by ROTHBERG JONATHAN M, Director. Officer active across 3 companies, notably Quantum-Si Inc. Cumulatively, 10 reports have been logged. Total volume traded: €190k. The latest transaction was filed on 17 June 2022 — Attribution. Regulator: SEC (Form 4). All data is openly available.
Declarations10 total
048,231 shares0
Class A Common Stock
SEC:0001104659-22-073489:0·
€75,83425,561 shares@ €2.9668100.0% of flow
Class A Common Stock
SEC:0001140361-22-023264:0·
Ideal exit: 11 Mar 2023 (T+270)
€114,39652,848 shares@ €2.16460.12% mcap100.0% of flow
Class A Common Stock
SEC:0001209191-22-036999:0·
Ideal exit: 11 Mar 2023 (T+270)
06,202,545 shares0
Class A Common Stock
SEC:0001104659-22-037171:0·
104,074 shares
Class A Common Stock
SEC:0001104659-22-002890·
104,074 shares
Class A Common Stock
SEC:0001104659-22-002890:0·
104,074 shares
Class A Common Stock
SEC:0001104659-21-153337·
104,074 shares
Class A Common Stock
SEC:0001104659-21-153337:0·
12,480,108 shares
Class A Common Stock
SEC:0001104659-21-080932·
12,480,108 shares
Class A Common Stock
SEC:0001104659-21-080932:0·
10 of 10 declarations
About ROTHBERG JONATHAN M
Jonathan M. Rothberg is a Board Member and Interim CEO of Quantum-Si Inc, Hyperfine, Inc., and Butterfly Network, Inc. In these roles, he provides strategic and operational expertise, guiding the companies through periods of transition. Jonathan M. Rothberg is recognized for his innovation in health technology, contributing to shaping the future of these companies. His leadership is essential in ensuring continuity and growth.
